I'm proof MEN can get breast cancer: Father-of-two, 59, tells of his four-year battle with predominantly 'female' disease - and urges other men to beware that they could be struck down too
David McCallion, 59, who lives in Oldham was diagnosed with breast cancer after noticing he had an inverted nipple. He recalls friends of 30 years would cross the road to avoid talking about cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 8, 2024 Category: Consumer Health News Source Type: news
Is semiannual mammo after breast conserving surgery necessary?
Annual mammography with a clinical exam -- rather than semiannual -- is “likely sufficient” for women who have undergone breast-conserving surgery and were treated with neoadjuvant therapy, a study published March 2 in Surgical Oncology Insight has found. Researchers led by Ton Wang, MD, from Cedars-Sinai Medical Center in Los Angeles found insufficient evidence supporting the use of semiannual mammography in these women, with less than 2% of women developing locoregional recurrence on routine surveillance. “Semiannual mammography is associated with unnecessary benign biopsies, which may increase health care costs ...
Source: AuntMinnie.com Headlines - March 8, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Imaging Source Type: news
MIDAC gives the nod to Lumicell ’s Lumisight
The Medical Imaging Drugs Advisory Committee (MIDAC) has voted in support of the benefit-risk profile of Lumisight.
During a March 5 meeting, MIDAC members voted 16 to 2 in favor of the company’s recent new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its Lumisight optical imaging agent for breast cancer and a premarket approval application (PMA) for the company's direct visualization system.
The company’s combined product is an intracavity, fluorescence-guided surgical imaging tool used to detect residual cancer in real-time during lumpectomy surgery, also known as breast-conserving surg...
Source: AuntMinnie.com Headlines - March 7, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Breast Imaging Source Type: news
Is Your Early Breast Cancer (EBC) Patient At High Risk of Recurrence? Is Your Early Breast Cancer (EBC) Patient At High Risk of Recurrence?
Clinicopathologic risk assessment and adherence support in patients with high-risk HR+/HER2- early breast cancerMedscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 7, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
CEUS shines in diagnostic, interventional settings
Dynamic contrast-enhanced ultrasound (CEUS) is a useful tool for interventions, according to a March 3 presentation given at ECR 2024. In his talk, Dean Huang, MD, from King’s College London in England outlined novel applications for CEUS in vascular and nonvascular imaging, as well as therapeutic and potential future applications. “Ultrasound contrast agent use can be ubiquitous in interventional practice and can solve many logistical or clinical diagnostic problems,” he said. “And we can achieve all of this without the use of radiation and nephrotoxicity.” Dean Huang, MD, from King's College London highligh...
Source: AuntMinnie.com Headlines - March 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Janice Burgess, Creator of ‘The Backyardigans,’ Dies at 72
Janice Burgess, the two-time Daytime Emmy winner who created the beloved animated musical series The Backyardigans for Nickelodeon, has died. She was 72. Burgess died Saturday in hospice care in Manhattan of breast cancer, her former Nickelodeon colleague Brown Johnson told The New York Times. The…#janiceburgess #daytimeemmy #burgess #manhattan #nickelodeon #brownjohnson #backyardigans #nickjr #tyrone #tasha (Source: Reuters: Health)
Source: Reuters: Health - March 5, 2024 Category: Consumer Health News Source Type: news
Outrage as thousands of breast cancer-stricken women in England are denied life-extending drug available in Scotland
Campaigners said the decision was a 'dark day' for patients after the National Institute for Health and Care Excellence watchdog said the drug, Enhertu, is not cost-effective. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2024 Category: Consumer Health News Source Type: news
Quebec expands referral-free breast cancer screening to 70- to 74-year-olds
Quebec is expanding its breast cancer screening program, which offers free mammograms without a doctor's referral, beyond the 50 to 69 year-old age category. (Source: CBC | Health)
Source: CBC | Health - March 5, 2024 Category: Consumer Health News Tags: News/Canada/Montreal Source Type: news
Woman who exercised 5 times a week and only ate organic is shocked after finding cancerous lump- as she BLAMES drinking alcohol and stress from her job
Jessica White, 38, from Idaho, says she was shocked when she was diagnosed with breast cancer. The entrepreneur said she was always healthy, doing hot yoga and eating organic. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2024 Category: Consumer Health News Source Type: news
Breast cancer fears for almost 1,500 women at 'very high risk' of disease after 'historic' blunder meant they weren't invited for annual NHS check-ups
The error meant women who received radiotherapy treatment for Hodgkin lymphoma between 1962 and 2003 were not contacted for annual breast cancer check ups. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2024 Category: Consumer Health News Source Type: news
eEF1A2 promotes PTEN-GSK3 β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer | Science Signaling
PTEN and the translation factor eEF1A2 repress breast cancer cells. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - March 5, 2024 Category: Science Source Type: news
NHS watchdog blocks breast cancer drug in England
Nice fails to approve Enhertu due to value-for-money concerns despite it being recommended in Scotland (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 5, 2024 Category: Pharmaceuticals Source Type: news
Faster diagnostic pathways: implementing a timed breast cancer diagnostic pathway: guidance for local health and social care systems
NHS England - This guidance will support cancer alliances and constituent organisations to adopt consistent, system-wide approaches to managing this diagnostic pathway. It sets out how diagnosis within 28-days can be achieved for the suspected breast cancer pathway. Alongside the pathway itself, resources, including an audit tool, are highlighted to support implementation of the pathway.GuidanceMore detail (Source: The Kings Fund - Health Management Specialist Collection)
Source: The Kings Fund - Health Management Specialist Collection - March 5, 2024 Category: Health Management Authors: The King ' s Fund Library Tags: NHS performance and productivity Source Type: news
Social determinants of health influence breast cancer screening uptake
Socioeconomic factors arising from social determinants of health can influence adherence to breast cancer screening, researchers have found.
A team led by Lea Sacca, PhD, from Florida Atlantic University in Boca Raton found that insurance status, income, age, and ethnicity are some of the most influential factors in women being able to access breast cancer screening resources. The findings were published February 6 in Frontiers in Public Health, according to a March 4 statement released by the university.
“Efforts to integrate social determinants of health within the different components of intervention planning, impl...
Source: AuntMinnie.com Headlines - March 5, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Breast Breast Imaging Source Type: news
The First Over-the-Counter Birth Control Pill Is Here
The first birth control pill that people can buy without a prescription, called Opill, is shipping to stores this week.
Perrigo, the Ireland-based company that makes Opill, said the pills should be available to purchase at retail pharmacies and online by the end of March. The pills are designed to be taken daily at about the same time each day, and they will be sold in one-month packs for $19.99 and three-month packs for $49.99.
[time-brightcove not-tgx=”true”]
A spokesperson for CVS, one pharmacy that will be stocking the pill, said the pills will be in more than 7,500 of its stores nationwide and will ...
Source: TIME: Health - March 4, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
